Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck reorganises European operations

Appoints João Rocha and Michael Quiqueran-Beajeu as regional vice presidents

Lundbeck has split its European activities into two regional units and appointed João Rocha and Michael Quiqueran-Beajeu to lead them.

The Danish pharma company has promoted Rocha from country manager in Brazil and regional vice president for Latin America to vice president of its new Region West unit.

Prior to joining Lundbeck he served with Merck and Schering-Plough and in his new role will have responsibility for Lundbeck's commercial activities in the majority of Western European countries.

Meanwhile Quingueran-Beajeuwill joins Lundbeck from Genzyme, where he was senior vice president and general manager for Northern Europe. He has more than 20 years of experience in the European pharmaceutical industry and previously worked for companies such as Sandoz and Roche.

He will now lead Lundbeck's operations in Eastern Europe as well as Turkey and Russia.

"Europe is still Lundbeck's largest market, and with our growing drug portfolio and several new launches in the near future, it is important that we consolidate and strengthen our European organisation," said Marie-Laure Pochon, Lundbeck's executive vice president for commercial operations.

"With our new structure and the appointment of João Rocha and Michael Quiqueran-Beaujeu, who both bring with them many years of experience and impressive results, I am convinced that we have a set-up that gives us the optimal conditions for success in developing and expanding the Lundbeck business."

New products on the horizon include the company's alcohol dependence treatment Selincro (nalmefene), which was filed for European approval in December.

And earlier this year Lundbeck launched its antipsychotic Sycrest (asenapine) in UK, following its EU debut in Denmark last year.

Europe accounts for 50 per cent of Lundbeck's revenue, which last year rose two per cent to DKK 8bn (€1.1bn) in 2011.

10th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics